Search
Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma
- OPACC
- Mar 7, 2024
- 1 min read
Roberto Chiarle, MD, at Boston Children's Hospital and his colleagues now report a way to make CAR-T cell therapy work better in neuroblastoma. They hope to begin testing it soon in children at high risk.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comments